These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37272641)

  • 1. Vertigo and Dizziness After Coronavirus Disease-2019 Vaccination: A Nationwide Analysis.
    Kim SH; Yon DK; Choi YS; Lee J; Park KH; Lee YJ; Park DC; Kim SS; Rim HS; Yeo SG
    J Int Adv Otol; 2023 Jun; 19(3):228-233. PubMed ID: 37272641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vertigo/dizziness following COVID-19 vaccination.
    Yan HY; Young YH
    Am J Otolaryngol; 2023; 44(2):103723. PubMed ID: 36502671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study.
    Lee DS; Kim JW; Lee KL; Jung YJ; Kang HW
    Int J Infect Dis; 2022 May; 118():173-182. PubMed ID: 35276381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking the COVID-19 vaccines: The global landscape.
    Yadav T; Kumar S; Mishra G; Saxena SK
    Hum Vaccin Immunother; 2023 Dec; 19(1):2191577. PubMed ID: 36995773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom.
    Otero-Losada M; Petrovsky N; Alami A; Crispo JA; Mattison D; Capani F; Goetz C; Krewski D; Perez-Lloret S
    Expert Opin Drug Saf; 2023 Apr; 22(4):343-349. PubMed ID: 36043937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
    Stuart ASV; Shaw RH; Liu X; Greenland M; Aley PK; Andrews NJ; Cameron JC; Charlton S; Clutterbuck EA; Collins AM; Darton T; Dinesh T; Duncan CJA; England A; Faust SN; Ferreira DM; Finn A; Goodman AL; Green CA; Hallis B; Heath PT; Hill H; Horsington BM; Lambe T; Lazarus R; Libri V; Lillie PJ; Mujadidi YF; Payne R; Plested EL; Provstgaard-Morys S; Ramasamy MN; Ramsay M; Read RC; Robinson H; Screaton GR; Singh N; Turner DPJ; Turner PJ; Vichos I; White R; Nguyen-Van-Tam JS; Snape MD;
    Lancet; 2022 Jan; 399(10319):36-49. PubMed ID: 34883053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data.
    Primorac Padjen E; Marcec R; Zidar M; Padjen I; Katanec T; Anic B; Likic R
    Rheumatol Int; 2024 Feb; 44(2):273-281. PubMed ID: 38142450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis.
    Gil-Díaz A; Gil-Hernández A; Lozano-Jiménez AI; Benítez-Peña J; Conde-Martel A
    Thromb Res; 2022 Jan; 209():84-85. PubMed ID: 34896915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.
    Botton J; Jabagi MJ; Bertrand M; Baricault B; Drouin J; Le Vu S; Weill A; Farrington P; Zureik M; Dray-Spira R
    Ann Intern Med; 2022 Sep; 175(9):1250-1257. PubMed ID: 35994748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [COVID-19 infections and effectiveness of the vaccination among healthcare workers].
    Rojkovich B; Németh D; Dinya E; Nagy E; Török E; Lázár I; Perduk A; Géher P; Nagy G
    Orv Hetil; 2023 Feb; 164(5):163-171. PubMed ID: 36739547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis.
    Singh RB; Parmar UPS; Kahale F; Agarwal A; Tsui E
    Ophthalmology; 2023 Feb; 130(2):179-186. PubMed ID: 36055601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States.
    Abara WE; Gee J; Marquez P; Woo J; Myers TR; DeSantis A; Baumblatt JAG; Woo EJ; Thompson D; Nair N; Su JR; Shimabukuro TT; Shay DK
    JAMA Netw Open; 2023 Feb; 6(2):e2253845. PubMed ID: 36723942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of digestive symptoms after COVID-19 vaccination: A retrospective single-center study.
    Lee DS; Kim JW; Lee KL; Jung YJ; Kang HW
    Am J Emerg Med; 2022 Aug; 58():154-158. PubMed ID: 35691237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transverse Myelitis Following SARS-CoV-2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database.
    Nguyen S; Bastien E; Chretien B; Sassier M; Defer G; Nehme A; Lelong-Boulouard V; Alexandre J; Fedrizzi S; Morice PM
    Ann Neurol; 2022 Dec; 92(6):1080-1089. PubMed ID: 36054163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
    Maruyama A; Sawa T; Teramukai S; Katoh N
    J Infect Chemother; 2022 Jul; 28(7):934-942. PubMed ID: 35361536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of COVID-19 vaccine subtypes, efficacy and geographical distributions.
    Francis AI; Ghany S; Gilkes T; Umakanthan S
    Postgrad Med J; 2022 May; 98(1159):389-394. PubMed ID: 37066438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis.
    Kim JH; Yoon D; Ko HY; Jung K; Sunwoo JS; Shin WC; Byun JI; Shin JY
    BMC Med; 2024 Mar; 22(1):123. PubMed ID: 38486297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An observational study of adverse drug reactions to COVID-19 vaccines reported to the New Mexico poison center hotline.
    Tadfor Y; Nguyen-Hua N; Bennett H; Bos AJ; Smolinske SC
    Clin Toxicol (Phila); 2023 Jan; 61(1):77-83. PubMed ID: 36458888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous prime-boost strategies for COVID-19 vaccines.
    Sapkota B; Saud B; Shrestha R; Al-Fahad D; Sah R; Shrestha S; Rodriguez-Morales AJ
    J Travel Med; 2022 May; 29(3):. PubMed ID: 34918097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.